Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Statement Regarding the Prevention of Illegal Activities Under the Guise of "Health Element"
Time Posted：2024-12-26 13:20
At 8:40 am today, the group received a report that criminals were developing and operating the "Healthy Element" APP platform under the guise of the group, publishing and selling financial management products, and carrying out fraud. In response to this situation, the group makes the following solemn statement:
Time Posted：2024-12-05 14:35
Recently, we received notification from the National Pharmacopoeia Commission that the generic name application for Health Yuan's innovative influenza drug has been approved. It has been officially named "Mapaxisave" (the Chinese generic name for the raw material is "Mapaxisave", and the English name is "Pixavir Marboxil"; the Chinese generic name for the preparation is "Mapaxisave Capsules", and the English name is "Pixavir Marboxil Capsules").
ESG performance is eye-catching, and Health Yuan's MSCI rating has jumped to AA.
Time Posted：2023-10-31 14:11
Recently, MSCI, a leading international index provider, announced the results of its 2023 ESG (Environmental, Social, and Governance) rating for HealthGen. HealthGen's ESG rating was upgraded from "BBB" to "AA", a leading level in the industry. This upgrade reflects not only the recognition of HealthGen's ESG management achievements by the international capital market, but also its affirmation of its long-term sustainable development capabilities.
Time Posted：2023-03-30 18:23
What impact and disruption will ChatGPT have on the biopharmaceutical industry? Could the next innovative drug be AI-invented? Recently, following the global popularity of ChatGPT, various industries have begun to pay close attention to the power of technological transformation. The AI concept continues to empower various industries, and the pharmaceutical and medical fields are also being catalyzed by it. In fact, the application of AI in the pharmaceutical and medical fields has gradually transitioned from exploratory practice to commercial transformation. Many companies are already deploying in the AI pharmaceutical field. In the capital market, many institutions have suggested focusing on "AI + medical", "AI + pharmaceutical", and "AI +" opportunities. Hu'an Securities - Pharmaceutical and Biological Research Report points out that AI is a major annual theme, and it is recommended to participate throughout the year, especially companies with landing scenarios and revenue.
Joincare Pharmaceutical Group Industry Co., Ltd. Responsible Artificial Intelligence (AI) Use Policy
Time Posted：2026-04-24 11:30
This Policy is established to govern the application of Artificial Intelligence ("AI") technologies in the operations and management of Joincare Pharmaceutical Group Co., Ltd. (the "Company") and its subsidiaries, to promote the safe, compliant, prudent, transparent and environmentally responsible use of AI, and to mitigate associated risks, having regard to the Company’s specific circumstances.
Joincare Pharmaceutical Group Industry Co., Ltd. Sustainable Development Management System
Time Posted：2025-08-22 09:44
Joincare Pharmaceutical Group Industry Co., Ltd. Anti-corruption and Anti-commercial Bribery System
Time Posted：2025-08-22 00:00
Joincare Pharmaceutical Industry Group Co., Ltd. Information Security and Privacy Protection Policy
Time Posted：2025-07-25 11:18
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.